-+ 0.00%
-+ 0.00%
-+ 0.00%

Ladenburg Thalmann Initiates Coverage On Decoy Therapeutics with Buy Rating, Announces Price Target of $2.5

Benzinga·01/23/2026 12:29:22
Listen to the news
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Decoy Therapeutics (NASDAQ:DCOY) with a Buy rating and announces Price Target of $2.5.